HIV/AIDS, PrEP
Conditions
Keywords
Feasibility, Implementation
Brief summary
Despite an increasing armamentarium of behavioral and biomedical HIV prevention methods, since 2010 rates of new infection have remained around 40,000 annually. The demonstrated efficacy and subsequent approval of emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis (PrEP) for HIV by the FDA in 2012 was thought to represent a turning point that could significantly reduce the number of new infections. Since approval, the promise of PrEP as a transformative intervention has yet to be realized. Despite the implementation of systems for clinical evaluation for and initiation of PrEP by primary care providers, HIV specialists, and STI clinics, numerous barriers to PrEP expansion have been identified, including: 1) patient and provider lack of knowledge, 2) lack of access to medical care among high-risk individuals, 3) provider discomfort and inexperience with screening for risk behaviors, and 4) insurance and affordability. This proposal seeks to expand access to and engagement in PrEP among high risk individuals though an innovative delivery approach in the Emergency Department (ED) while addressing these four barriers.
Detailed description
Aim 1: Initiate a targeted ED-based PrEP screening program and optimize its feasibility and acceptability. 1. Behavioral risk factor eligibility screening will be performed using the ICAP Pre-Exposure Prophylaxis (PrEP) Screening for Substantial Risk and Eligibility tool. 2. During a 3-month period, use continuous quality improvement methods to decrease the time for completion of PrEP eligibility screening to an interval that is acceptable to ED patients and providers. Aim 2: Pre-Exposure Prophylaxis Provision in the ED (PrEPPED) Trial: Identify 40 PrEP eligible patients over a 12-month period who are interested in initiating PrEP in the ED. These patients will be offered immediate PrEP (iPrEP) initiation in the ED with facilitated linkage to comprehensive out-patient care. 1. Evaluate the impact of a PrEP starter pack on patients agreeing to iPrEP. The primary outcome is engagement in care at 30-days post PrEP initiation visit. Secondary outcomes include retention in care, STI diagnosis, risk behavior and PrEP adherence. 2. Collect data on recruitment and attrition rates, as well as means and standard deviations for key measures that will be needed to plan a definitive trial of ED-initiated PrEP.
Interventions
ICAP Pre-Exposure Prophylaxis (PrEP) Screening for Substantial Risk and Eligibility tool
emtricitabine/tenofovir alafenamide or emtricitabine/tenofovir disoproxil
Sponsors
Study design
Intervention model description
Part 1 of study will enroll 30 participants. Part 2 of study will enroll 40 participants
Eligibility
Inclusion criteria
PrEP screen group: * Patients 18 years of age and above * Medically stable as determined by their provider * Able to speak English * Willing and able to consent to study participation. * Not requiring hospital admission for ongoing care. iPrep group: * ED patients 18 years of age and above * HIV negative determined by 4th generation rapid testing with no evidence of acute HIV infection as determined by their ED provider * Medically stable as determined by their primary provider * Able to speak English * Able to consent to participation * Contact information available for linkage * Not requiring hospital admission for ongoing care. * Eligible for PrEP based on CDC risk behavior and clinical criteria.
Exclusion criteria
PrEP screen group: * ED patients younger than 18 years of age * Medically or psychiatrically unstable as determined by the ED provider * Unable to speak or understand English * Unable to provide consent for study participation. * Being admitted to the hospital for ongoing care iPrEP group: * ED patients younger than 18 years of age * Known HIV positive or positive rapid HIV test in ED * Medically or psychiatrically unstable as determined by the ED provider * Unable to speak or understand English * Unable to provide consent for study participation * No means of re-contact upon ED discharge * No behavioral risk factors indicating need for PrEP * Medical contraindications to PrEP * Pregnant or breastfeeding
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Engagement in Care (Implementation Component) | 30 days post-ED visit | Engagement is care is defined by attending at least 1 out-patient clinic appointment with a PrEP provider within 30-days of the ED visit. |
| Number of Participants on PrEP Usage | 90 days | — |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| CDC Sexual Behavior Questions (CSBQ) (RCT Component) | 30 days post-ED visit | CDC Sexual Behavior Questions (CSBQ) to measure HIV risk behavior. CSBQ is a multi-tiered, gender-specific questionnaire developed by the Centers for Disease Control and Prevention HIV-STID Behavioral Surveillance Working Group. Three separate domains - Sexual Behavior, Drug-related HIV risk, and HIV testing. Responses are yes/no with no summation. Number of participants who engaged in unsafe sexual behavior, was under substance influence and who had a HIV test. |
| PrEPPED Satisfaction and Acceptability Survey (RCT Component) | 30 days post-ED visit | PrEPPED Satisfaction and Acceptability Survey is a patient satisfaction questionnaire was developed by the study team. It's a series of independent Likert questions from 1-6 addressing different aspects of the program. Full scale from 0 to 18, with higher score indicating more satisfaction. Satisfaction data were not collected at 30, 60, or 90 days. After study initiation, it was determined by the researchers that the satisfaction items were specific to the emergency department visit experience and not relevant to the follow-up period. Consequently, decision was made to not administer the follow-up satisfaction assessments, therefore, no data was collected so there is no data to report. |
| Number of Participants of New HIV Infection (RCT Component) | 90 days post-ED visit | Number of new HIV diagnosis at 90-days after enrollment. This question was only asked for those individuals who had not been lost to follow-up. |
| Number of Participants of New STI Diagnoses (RCT Component) | 30 days, 60 days, and 90 days post-ED visit | Number of new STI diagnosis between day 1 (day after enrollment) and day 90 (final day of follow-up) broken down into days 1-30, 31-60, 61-90. |
| The VSQ-9 is a Visit-specific Satisfaction Instrument (RCT Component) | 30 days post-ED visit | The VSQ-9 is a visit-specific satisfaction instrument adapted by the American Medical Guidelines Regimen Information Program (GRIP) survey. GRIP guide is a self-report to assess PrEP adherence at 30-days post ED visit, with 6 categorical items: excellent, very good, good, fair, poor, and very poor. Because participants were not required to follow up at a single clinic, post-discharge care settings varied widely. The VSQ-9 assesses satisfaction with a specific clinical encounter, and applying it across multiple, non-standardized settings was deemed inappropriate and unlikely to yield interpretable data. Therefore, decision was made by the researcher to not administer the VSQ-9 at 30, 60, or 90 days. Consequently, no follow-up VSQ-9 data were collected so there is no data to report. |
Countries
United States
Participant flow
Recruitment details
Of 1455 patients screened, 169 were eligible, 26 were randomized and received their assigned intervention.
Participants by arm
| Arm | Count |
|---|---|
| Out-patient Care for PrEP Initiation PrEP screening program with referral to out-patient care for PrEP initiation
PrEP screening program: ICAP Pre-Exposure Prophylaxis (PrEP) Screening for Substantial Risk and Eligibility tool | 13 |
| Immediate PreP Initiation PreP screening program with immediate PrEP (iPrEP) initiation in the ED using a PrEP starter pack with facilitated linkage to care.
PrEP screening program: ICAP Pre-Exposure Prophylaxis (PrEP) Screening for Substantial Risk and Eligibility tool
PrEP starter pack: emtricitabine/tenofovir alafenamide or emtricitabine/tenofovir disoproxil | 13 |
| Total | 26 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Lost to Follow-up | 7 | 8 |
Baseline characteristics
| Characteristic | Out-patient Care for PrEP Initiation | Total | Immediate PreP Initiation |
|---|---|---|---|
| Age, Continuous | 29.0 years | 32.5 years | 34 years |
| Covered by health insurance/health plan | 12 Participants | 24 Participants | 12 Participants |
| Current living situation In a rooming, boarding, or halfway house | 0 Participants | 1 Participants | 1 Participants |
| Current living situation On the street(s) (Vacant lot, abandoned building, park, etc.) | 0 Participants | 1 Participants | 1 Participants |
| Current living situation Other | 0 Participants | 1 Participants | 1 Participants |
| Current living situation Own or rent home/apartment | 12 Participants | 19 Participants | 7 Participants |
| Current living situation Shelter | 1 Participants | 3 Participants | 2 Participants |
| Current living situation Staying at home of friend(s)/other | 0 Participants | 1 Participants | 1 Participants |
| Estimated annual total income < $1000 | 1 Participants | 3 Participants | 2 Participants |
| Estimated annual total income $10,001-$20,000 | 1 Participants | 2 Participants | 1 Participants |
| Estimated annual total income $1001-$2500 | 0 Participants | 1 Participants | 1 Participants |
| Estimated annual total income $20,001-$40,000 | 0 Participants | 3 Participants | 3 Participants |
| Estimated annual total income $40,001 or more | 5 Participants | 9 Participants | 4 Participants |
| Estimated annual total income $5001-$10,000 | 1 Participants | 1 Participants | 0 Participants |
| Estimated annual total income Don't know | 3 Participants | 5 Participants | 2 Participants |
| Estimated annual total income Missing | 2 Participants | 2 Participants | 0 Participants |
| Ethnicity (NIH/OMB) Hispanic or Latino | 2 Participants | 6 Participants | 4 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 10 Participants | 17 Participants | 7 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 1 Participants | 3 Participants | 2 Participants |
| Experiencing homelessness No | 13 Participants | 23 Participants | 10 Participants |
| Experiencing homelessness Yes | 0 Participants | 3 Participants | 3 Participants |
| Frequency of having run out of money for basic necessities in the past year Daily | 0 Participants | 2 Participants | 2 Participants |
| Frequency of having run out of money for basic necessities in the past year Monthly | 1 Participants | 2 Participants | 1 Participants |
| Frequency of having run out of money for basic necessities in the past year Never | 6 Participants | 12 Participants | 6 Participants |
| Frequency of having run out of money for basic necessities in the past year Occasionally | 3 Participants | 5 Participants | 2 Participants |
| Frequency of having run out of money for basic necessities in the past year Prefer not to answer | 1 Participants | 1 Participants | 0 Participants |
| Frequency of having run out of money for basic necessities in the past year Weekly | 2 Participants | 4 Participants | 2 Participants |
| Highest level of education College graduate (4-year college or university) | 3 Participants | 6 Participants | 3 Participants |
| Highest level of education High school graduate/GED or equivalent | 5 Participants | 10 Participants | 5 Participants |
| Highest level of education Missing | 0 Participants | 1 Participants | 1 Participants |
| Highest level of education Post-college/graduate degree | 1 Participants | 1 Participants | 0 Participants |
| Highest level of education Some college (4-year college or university) | 3 Participants | 5 Participants | 2 Participants |
| Highest level of education Some high school, no diploma | 1 Participants | 3 Participants | 2 Participants |
| Past-year employment status Disabled | 2 Participants | 3 Participants | 1 Participants |
| Past-year employment status Looking for work/unemployed | 3 Participants | 6 Participants | 3 Participants |
| Past-year employment status Prefer not to answer | 1 Participants | 1 Participants | 0 Participants |
| Past-year employment status Student | 0 Participants | 1 Participants | 1 Participants |
| Past-year employment status Working full time | 5 Participants | 9 Participants | 4 Participants |
| Past-year employment status Working part time | 2 Participants | 6 Participants | 4 Participants |
| Race/Ethnicity, Customized Asian | 0 Participants | 1 Participants | 1 Participants |
| Race/Ethnicity, Customized Black or African American | 4 Participants | 12 Participants | 8 Participants |
| Race/Ethnicity, Customized Missing | 1 Participants | 1 Participants | 0 Participants |
| Race/Ethnicity, Customized More than one race | 3 Participants | 5 Participants | 2 Participants |
| Race/Ethnicity, Customized White | 5 Participants | 7 Participants | 2 Participants |
| Sex: Female, Male Female | 2 Participants | 4 Participants | 2 Participants |
| Sex: Female, Male Male | 11 Participants | 22 Participants | 11 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 0 | 0 / 0 |
| other Total, other adverse events | 0 / 0 | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 | 0 / 0 |
Outcome results
Engagement in Care (Implementation Component)
Engagement is care is defined by attending at least 1 out-patient clinic appointment with a PrEP provider within 30-days of the ED visit.
Time frame: 30 days post-ED visit
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Out-patient Care for PrEP Initiation | Engagement in Care (Implementation Component) | 1 Participants |
| Immediate PreP Initiation | Engagement in Care (Implementation Component) | 1 Participants |
Number of Participants on PrEP Usage
Time frame: 90 days
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Out-patient Care for PrEP Initiation | Number of Participants on PrEP Usage | 1 Participants |
| Immediate PreP Initiation | Number of Participants on PrEP Usage | 2 Participants |
CDC Sexual Behavior Questions (CSBQ) (RCT Component)
CDC Sexual Behavior Questions (CSBQ) to measure HIV risk behavior. CSBQ is a multi-tiered, gender-specific questionnaire developed by the Centers for Disease Control and Prevention HIV-STID Behavioral Surveillance Working Group. Three separate domains - Sexual Behavior, Drug-related HIV risk, and HIV testing. Responses are yes/no with no summation. Number of participants who engaged in unsafe sexual behavior, was under substance influence and who had a HIV test.
Time frame: 30 days post-ED visit
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Out-patient Care for PrEP Initiation | CDC Sexual Behavior Questions (CSBQ) (RCT Component) | Sexual Behavior | 4 Participants |
| Out-patient Care for PrEP Initiation | CDC Sexual Behavior Questions (CSBQ) (RCT Component) | Drug-related HIV risk | 2 Participants |
| Out-patient Care for PrEP Initiation | CDC Sexual Behavior Questions (CSBQ) (RCT Component) | HIV testing | 0 Participants |
| Immediate PreP Initiation | CDC Sexual Behavior Questions (CSBQ) (RCT Component) | Sexual Behavior | 5 Participants |
| Immediate PreP Initiation | CDC Sexual Behavior Questions (CSBQ) (RCT Component) | Drug-related HIV risk | 2 Participants |
| Immediate PreP Initiation | CDC Sexual Behavior Questions (CSBQ) (RCT Component) | HIV testing | 0 Participants |
Number of Participants of New HIV Infection (RCT Component)
Number of new HIV diagnosis at 90-days after enrollment. This question was only asked for those individuals who had not been lost to follow-up.
Time frame: 90 days post-ED visit
Population: Number of new HIV diagnosis at 90-days after enrollment. This question was only asked for those individuals who had not been lost to follow-up.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Out-patient Care for PrEP Initiation | Number of Participants of New HIV Infection (RCT Component) | 0 Participants |
| Immediate PreP Initiation | Number of Participants of New HIV Infection (RCT Component) | 0 Participants |
Number of Participants of New STI Diagnoses (RCT Component)
Number of new STI diagnosis between day 1 (day after enrollment) and day 90 (final day of follow-up) broken down into days 1-30, 31-60, 61-90.
Time frame: 30 days, 60 days, and 90 days post-ED visit
Population: Number of new STI diagnosis between day 1 (day after enrollment) and day 90 (final day of follow-up) broken down into days 1-30, 31-60, 61-90. Number analyzed at each time differ due to participants being lost to follow-up.
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Out-patient Care for PrEP Initiation | Number of Participants of New STI Diagnoses (RCT Component) | day 1 to day 30 | 1 Participants |
| Out-patient Care for PrEP Initiation | Number of Participants of New STI Diagnoses (RCT Component) | day 31 to day 60 | 0 Participants |
| Out-patient Care for PrEP Initiation | Number of Participants of New STI Diagnoses (RCT Component) | day 61 to day 90 | 0 Participants |
| Immediate PreP Initiation | Number of Participants of New STI Diagnoses (RCT Component) | day 61 to day 90 | 0 Participants |
| Immediate PreP Initiation | Number of Participants of New STI Diagnoses (RCT Component) | day 1 to day 30 | 2 Participants |
| Immediate PreP Initiation | Number of Participants of New STI Diagnoses (RCT Component) | day 31 to day 60 | 0 Participants |
PrEPPED Satisfaction and Acceptability Survey (RCT Component)
PrEPPED Satisfaction and Acceptability Survey is a patient satisfaction questionnaire was developed by the study team. It's a series of independent Likert questions from 1-6 addressing different aspects of the program. Full scale from 0 to 18, with higher score indicating more satisfaction. Satisfaction data were not collected at 30, 60, or 90 days. After study initiation, it was determined by the researchers that the satisfaction items were specific to the emergency department visit experience and not relevant to the follow-up period. Consequently, decision was made to not administer the follow-up satisfaction assessments, therefore, no data was collected so there is no data to report.
Time frame: 30 days post-ED visit
Population: No protocol amendment was generated for this Outcome Measure. Although the outcome was prespecified in the initial protocol, the study team ultimately determined during implementation that the required data elements could not be collected reliably across sites. Because this decision did not alter the study intervention, eligibility criteria, procedures, or primary outcome, and because no participant-facing activities were affected, the team did not submit a formal protocol amendment at the time.
The VSQ-9 is a Visit-specific Satisfaction Instrument (RCT Component)
The VSQ-9 is a visit-specific satisfaction instrument adapted by the American Medical Guidelines Regimen Information Program (GRIP) survey. GRIP guide is a self-report to assess PrEP adherence at 30-days post ED visit, with 6 categorical items: excellent, very good, good, fair, poor, and very poor. Because participants were not required to follow up at a single clinic, post-discharge care settings varied widely. The VSQ-9 assesses satisfaction with a specific clinical encounter, and applying it across multiple, non-standardized settings was deemed inappropriate and unlikely to yield interpretable data. Therefore, decision was made by the researcher to not administer the VSQ-9 at 30, 60, or 90 days. Consequently, no follow-up VSQ-9 data were collected so there is no data to report.
Time frame: 30 days post-ED visit
Population: No protocol amendment was generated for this Outcome Measure. Although the outcome was prespecified in the initial protocol, the study team ultimately determined during implementation that the required data elements could not be collected reliably across sites. Because this decision did not alter the study intervention, eligibility criteria, procedures, or primary outcome, and because no participant-facing activities were affected, the team did not submit a formal protocol amendment at the time.